Rapid Diagnosis of Myocardial Damage and Coronary Stenosis With Magnetic Resonance Imaging (MRI)

This study has been completed.
Sponsor:
Collaborators:
Jonkoping County Hospital
Medical Research Council of Southeast Sweden
Information provided by:
University Hospital, Linkoeping
ClinicalTrials.gov Identifier:
NCT00188123
First received: September 15, 2005
Last updated: July 14, 2009
Last verified: September 2005
  Purpose

The hypothesis is that single-shot imaging of myocardial infarction is possible in atrial fibrillation using MRI late enhancement technique


Condition Phase
Myocardial Infarction
Phase 4

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Rapid Diagnosis of Myocardial Damage and Coronary Stenosis With MRI

Resource links provided by NLM:


Further study details as provided by University Hospital, Linkoeping:

Enrollment: 20
Study Start Date: April 2004
Study Completion Date: April 2009
Primary Completion Date: September 2005 (Final data collection date for primary outcome measure)
Detailed Description:

50 outpatients in Jonkoping County with a diagnosis of in-hospital myocardial infarction, are asked to participate in this study comparing segmented true FISP late enhancement with single-shot trueFISP late enhancement for the diagnosis of myocardial damage. The study does not intervene regarding treatment but is a comparison of the diagnostic power of the two MRI techniques.

  Eligibility

Ages Eligible for Study:   20 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patient with an in-hospital diagnosis of myocardial infarction having permanent atrial fibrillation.

Criteria

Inclusion Criteria:

in-hospital diagnosis of myocardial infarction

Exclusion Criteria:

pacemaker, not willing to participate, metallic objects in brain or eyes,

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00188123

Locations
Sweden
Varnamo Hospital
Varnamo, Sweden, SE33185
Sponsors and Collaborators
University Hospital, Linkoeping
Jonkoping County Hospital
Medical Research Council of Southeast Sweden
Investigators
Principal Investigator: Jan E Engvall, MD, PhD University Hospital, Linkoeping
  More Information

No publications provided

Responsible Party: Linkoping universitet
ClinicalTrials.gov Identifier: NCT00188123     History of Changes
Other Study ID Numbers: 151:2004/8333 MPA Sweden
Study First Received: September 15, 2005
Last Updated: July 14, 2009
Health Authority: Sweden: Medical Products Agency

Keywords provided by University Hospital, Linkoeping:
Myocardial infarction
MRI late enhancement
Atrial fibrillation

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Coronary Stenosis
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Coronary Disease

ClinicalTrials.gov processed this record on July 22, 2014